Dihydropyrimidine dehydrogenase deficiency: impact of pharmacogenetics on 5-fluorouracil therapy.

Clinical advances in hematology & oncology : H&O

Volumn 2, Issue 8, 2004, Pages 527-532

  Lee, Adam ^a   Ezzeldin, Hany ^a   Fourie, Jeanne ^a   Diasio, Robert ^a  

^a The Purdue Univ Univ of Alabama at Birmingham Botanical Center for Age Related Disease   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5-FLUOROURIDINE 5'-TRIPHOSPHATE; ANTIDOTE; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYURIDINE PHOSPHATE; DIHYDROPYRIMIDINE DEHYDROGENASE; DRUG DERIVATIVE; FLOXURIDINE; FLUORODEOXYURIDINE TRIPHOSPHATE; FLUOROURACIL; FLUOROURIDINE TRIPHOSPHATE; PRODRUG; PYRIMIDINE NUCLEOSIDE; THYMIDYLATE SYNTHASE; URIDINE TRIPHOSPHATE;

BIOTRANSFORMATION; CHEMICALLY INDUCED DISORDER; DIARRHEA; DRUG DETOXIFICATION; DRUG ERUPTION; FEVER; GENETICS; HUMAN; MASS SCREENING; METABOLISM; MUCOSA INFLAMMATION; MUTATION; NUCLEOTIDE SEQUENCE; REVIEW;

ANTIDOTES; ANTIMETABOLITES, ANTINEOPLASTIC; BIOTRANSFORMATION; DEOXYURACIL NUCLEOTIDES; DIARRHEA; DIHYDROURACIL DEHYDROGENASE (NADP); DNA MUTATIONAL ANALYSIS; DRUG ERUPTIONS; FEVER; FLOXURIDINE; FLUOROURACIL; HUMANS; MASS SCREENING; METABOLIC DETOXICATION, DRUG; MUCOSITIS; MUTATION; PRODRUGS; PYRIMIDINE NUCLEOSIDES; THYMIDYLATE SYNTHASE; URIDINE TRIPHOSPHATE;

EID: 33747169515     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)